Business Wire

LUOHAN-ACADEMY

24.1.2019 15:10:10 CET | Business Wire | Press release

Share
Luohan Academy Unveils Report on Digital Technology and Inclusive Growth at World Economic Forum

Luohan Academy – an open research institute initiated by Alibaba Group Holding Limited (NYSE: BABA) – today released its first report examining the oft-debated relationship between digital technology and economic growth at the 2019 World Economic Forum in Davos. The report demonstrates how digital technology can drive inclusive growth in ways previous technology revolutions have not, especially when policies and public-private sector cooperation are supportive.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190124005445/en/

The report was launched at an event co-hosted with the World Bank, and featured speeches and discussions with high-profile experts, including Her Majesty Queen Máxima of the Netherlands and the UN Secretary-General's Special Advocate for Inclusive Finance for Development (UNSGSA); Kristalina Georgieva, CEO of the World Bank; Michael Spence, Professor of Economics at New York University and Nobel Prize Winner; Jack Ma, Alibaba Group Executive Chairman; and Chen Long, Director of Luohan Academy. More than 120 delegates from the World Economic Forum attended the launch event, including government officials, chief executives, academics, and heads of NGOs, international organizations and development agencies.

The report “Digital Technology and Inclusive Growth ” details why the benefits of the current digital revolution can be more evenly distributed than they were in previous technological revolutions. At the macro level, widespread adoption and application of digital technology is no longer dependent on level of income and economic development. At the micro level, digital technology is making it easier for consumers to start businesses, reach consumers, and access financing. Using China as a case study, the report illustrates how digital technologies can provide more access to economic opportunity in ways not possible previously.

“Experience in China and other emerging markets shows the tremendous potential of a new growth path, one that makes development more inclusive and sustainable,” said Chen Long, Director of Luohan Academy. “With public-private joint efforts and the right policies, the digital age presents new opportunities for emerging markets that did not exist before.”

This report identifies where digital technologies have made a material difference for inclusive growth in China, and offers some insights on how to apply the lessons learned in China to other markets. Some key findings include:

  • Lowering the skill threshold: In order to promote digital penetration, lowering the skill threshold needed to use technology is as important as raising the level of technological expertise. For example, in rural Taobao villages in China, e-tailer households that participate in e-commerce earn more than double the income of non-e-tailer households at every education level because the skills can be learned on the job; no formal education required.
  • Leveraging digital platforms: Digital platforms represent a new form of exchange and coordination to create an ecosystem for inclusive growth. It is a free-spinning wheel that connects numerous consumers and producers, and facilities interactions with very low cost, high efficiency, and reliability.
  • Forming effective public-private partnerships: It is more important than ever for the public sector to create a benign macro environment for the private sector to grow and make necessary investments for the population to access digital technology.
  • Managing unanticipated effects: In the digital age, there have been concerns about real and complex issues such as technological unemployment, abuse of private information, lagging competition policy, and increased inequality. The first step to address these challenges is to separate facts from speculation and anxiety. The evidence in China shows that the benefits of new market access and opportunities are more pronounced in less developed countries.

“This report on digitally enabled growth patterns in China is very interesting. The data shows that the mobile internet, e-commerce, mobile payments and internet-based financial services together have accelerated overall growth and produced startlingly inclusive growth patterns in multiple dimensions. The report documents this, and explains why these effects occur,” said Michael Spence, 2001 Nobel Prize Laureate in Economics and professor at New York University. “In conjunction with gained experience in other developing countries, there is a very convincing case that digitally-enabled, platform-based ecosystems are a new and powerful growth engine.”

Launched in June 2018 in Hangzhou, the Luohan Academy is focused on addressing universal challenges that arise from the rapid development of digital technologies. With 16 Nobel Prize laureates and prominent academics as committee members, the institute aims at bringing together the top scholars in the world to study the most pressing issues of the digital economy and advance the research of technology and its impact on humanity.

About Luohan Academy

Luohan Academy, an independent think tank and open research institute, was initiated by Alibaba Group on 26th June, 2018 in Hangzhou, China. It was launched by Jack Ma, Alibaba's founder and Executive Chairman, and 16 academic committee members. Luohan Academy intends to bring together the best thinkers in the world with first-hand practical insights into the digital economy in order to advance the research frontiers of digital technology and its impact on humanity. Its mission is two-fold: to understand how digital technology can help achieve common good; and to build a broad research community for systematic and in-depth learning, leading to new paradigms for solving the most pressing issues in digital society.

Contact:

Media: Holly Zhao Holly.zhao@alibaba-inc.com +1 (505) 469-3316

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye